Hospimax Healthcare Pvt Ltd
Everolimus (0.5mg)
Suregraft 0.5 Tablet is used for the prevention of organ rejection in transplant patients and in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Tablet
Suregraft 0.5 Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body's immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Suregraft 0.5 Tablet may be taken with or without food but it is better to take it at a fixed time.
Suregraft 0.5 Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
Suregraft 0.5 Tablet is given for the treatment of certain cancers and to prevent organ transplant rejection. It may affect male or female fertility; consult your doctor if you are planning to have a child. Inform your doctor straight away if you think you are getting a sore throat or if you have a high temperature. While you are taking Suregraft 0.5 Tablet do not take any vaccinations without talking to your doctor first. If you are having an operation or dental treatment, always tell the person carrying out the treatment that you are taking Suregraft 0.5 Tablet. Do not drink grapefruit juice while you are taking this medicine.
Regular monitoring is necessary while on Suregraft 0.5 Tablet. Your doctor will advise blood tests to check the counts of red and white blood cells, platelets, kidney function, liver function, blood glucose levels, and cholesterol levels.
You should avoid consuming grapefruit or grapefruit juice while taking Suregraft 0.5 Tablet, as this may increase the medicine's levels in your blood to harmful levels. Additionally, avoid live vaccinations and any possible contact with individuals who have received live vaccinations.
Suregraft 0.5 Tablet can cause serious side effects, including severe allergic reactions, angioedema, and kidney failure that can be severe and potentially life-threatening. It may also lead to infections or breathing problems.
Suregraft 0.5 Tablet is an anticancer medicine that belongs to the kinase inhibitor class of medications. It works by reducing the blood supply to tumors, slowing down cancer cell growth and spread.
Ensure you take Suregraft 0.5 Tablet either with food or without food consistently. Take the medicine whole with water; do not crush or chew it.
There is no set duration for treatment with Suregraft 0.5 Tablet. Continue taking the medication until clinical benefit is observed, unacceptable toxicity, or side effects occur.
The effect of Suregraft 0.5 Tablet on shrinking tumor size can only be monitored through regular brain scans as advised by your doctor and treatment plan.
Yes, Suregraft 0.5 Tablet is cytotoxic against human cancer cells of the breast, stomach, prostate, and kidneys (renal cell carcinoma).